Understanding GI tract cancers: Diagnosis to treatment

Written in association with: Dr Cheng Boon
Published: | Updated: 06/06/2024
Edited by: Kate Forristal

The intricate network of the gastrointestinal (GI) tract, responsible for digestion and nutrient absorption, is susceptible to a spectrum of cancers. These malignancies can arise anywhere along the GI tract, from the oesophagus to the rectum, presenting diverse challenges in diagnosis and management. Understanding the nuances of GI tract cancers, including their types, symptoms, risk factors, and treatment modalities, is paramount for effective intervention and improved outcomes. In his latest online article, Dr Cheng Boon gives us his insights.

Types of GI tract cancers:

Oesophageal cancer: This cancer manifests in the oesophagus, often revealing symptoms at advanced stages such as dysphagia (difficulty swallowing), unintentional weight loss, and chest pain.

 

Gastric (Stomach) cancer: Gastric cancer can develop in any part of the stomach and is linked to factors like chronic gastritis, Helicobacter pylori infection, smoking, and certain dietary patterns.

 

Colorectal cancer: Among the most prevalent GI tract cancers, colorectal cancer affects the colon or rectum. Symptoms may include alterations in bowel habits, rectal bleeding, abdominal discomfort, and unexplained weight loss.

 

Liver cancer: Hepatocellular carcinoma (HCC) predominates in liver cancer cases. Risk factors include chronic hepatitis B or C infections, excessive alcohol consumption, non-alcoholic fatty liver disease, and specific genetic predispositions.

 

Pancreatic cancer: Typically diagnosed in advanced stages, pancreatic cancer presents challenges in treatment. Symptoms such as abdominal pain, jaundice, weight loss, and digestive disturbances may indicate its presence.

 

Gallbladder and biliary tract cancer: Originating from gallbladder or bile duct tissues, these cancers, while relatively rare, may provoke symptoms like jaundice, abdominal pain, and nausea.

 

Symptoms and risk factors:

Common symptoms of GI tract cancers include persistent abdominal discomfort, changes in bowel habits, unexplained weight loss, difficulty swallowing, and jaundice.

 

Risk factors include age, family history, smoking, alcohol consumption, obesity, inflammatory conditions, and certain infections like H. pylori and hepatitis viruses.

 

Diagnosis and treatment:

Early detection significantly influences the prognosis of GI tract cancers. Diagnostic methods include endoscopy, imaging tests, and biopsies.

 

Treatment modalities range from surgery to chemotherapy, radiation therapy, and targeted therapy, tailored to the cancer type, stage, and patient's overall health.

 

Prevention and outlook:

While not all GI tract cancers are preventable, adopting a healthy lifestyle and undergoing regular screenings can mitigate risks. By fostering awareness, early detection, and comprehensive care, individuals can navigate GI tract cancers with greater resilience, enhancing both digestive health and overall well-being.

 

Dr Cheng Boon is an esteemed medical oncologist. You can schedule an appointment with Dr Boon on his Top Doctors profile.

By Dr Cheng Boon
Medical oncology

Dr Cheng Boon is an experienced consultant oncologist at Amethyst Radiotherapy specialising in gastrointestinal (GI) tract cancers, including those affecting the oesophagus, stomach, pancreas, liver, and more. He focuses on non-surgical treatments like immunotherapy, targeted therapies, chemotherapy, and radiotherapy, prioritising personalised care and minimising side effects through advanced techniques like next-generation sequencing (NGS).
 
As medical director at OncoDNA UK, Dr Boon contributes to the clinical interpretation of NGS reports, benefiting patients and clinicians. Additionally, he serves as a clinical radiation expert (CRE) for the MHRA, ensuring the safety of radiotherapy doses in UK clinical trials. Dr Boon's expertise drives advancements in cancer care, improving outcomes for patients across the country.

View Profile

Overall assessment of their patients


  • Related procedures
  • Prostate cancer
    Breast cancer
    Bone cancer
    Nervous system malformations
    Brain tumour
    Bone marrow cancers
    Testicular cancer
    Thyroid cancer
    Adrenal glands cancer
    Neuro-oncology
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.